Neurology Market Size & Share, By Type (Neurodegenerative Diseases, Neurovascular Diseases, Neuro-infectious Diseases, Others), Procedure (Multiple Sclerosis, Epilepsy, Parkinsons Disease, Alzheimers Disease, Stroke, Others), End User (Adult, Pediatric), Application (Hospitals, Clinics, Diagnostic Centers, Research Institutes, Others) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034

Report ID: FBI 6665| Published Date: Jan-2025| Format: PDF, Excel
Jump to Content
Market Outlook

Market Size and Growth Outlook

Neurology Market size is expected to see substantial growth, increasing from USD 3.57 billion in 2024 to USD 7.5 billion by 2034, at a CAGR of over 7.7%. By 2025, the industry revenue is estimated to be USD 3.82 billion.

Base Year Value (2024)
USD 3.57 billion
CAGR (2025-2034)
7.7%
Forecast Year Value (2034)
USD 7.5 billion
Historical Data Period
2019-2024
Largest Region
North America
Forecast Period
2025-2034

Get more details on this report

Request Free Sample Report
Snapshot

Neurology Market Intelligence Snapshot

Regional Market Dynamics

Segment Momentum

Market Expansion Drivers

Leading Market Participants

Forecast Snapshot

Global Market Forecast Snapshot

Market Outlook

Regional and Segment Outlook

Market Dynamics

Market Growth Drivers and Industry Trends

Growth Drivers & Opportunity: One of the major growth drivers in the neurology market is the increasing prevalence of neurological disorders such as dementia, epilepsy, and multiple sclerosis. As the global population ages, the risk of developing these conditions rises significantly, creating a heightened demand for effective diagnostic and therapeutic solutions. Advances in medical technology and research have enabled the development of new treatments and diagnostics, which further drive market growth. Additionally, the growing awareness of mental health and its intersection with neurological conditions has led to increased funding and investments in neurological research and healthcare services, providing a robust opportunity for market expansion. Another significant growth driver is the advancements in neuropharmaceuticals and medical devices. Breakthroughs in drug development, particularly in areas like biomarkers and personalized medicine, have enhanced treatment efficacy and safety profiles for various neurological conditions. Moreover, innovations in medical devices, such as neuromodulation therapies and implantable technologies, are expanding treatment possibilities and improving patient outcomes. The convergence of technology and healthcare is playing a pivotal role in revolutionizing how neurologic disorders are diagnosed and treated, thereby propelling the market forward. The third growth driver is the increasing demand for telemedicine and telehealth services. The COVID-19 pandemic has accelerated the adoption of remote healthcare solutions, allowing patients to access neurologists and other specialists from the comfort of their homes. This convenience not only improves patient adherence to treatment plans but also expands access to neurological care, particularly in underserved and rural areas. As telehealth technology continues to evolve, it offers substantial growth potential for the neurology market by creating more opportunities for patient engagement and follow-up care. Industry Restraints: Despite the positive outlook for the neurology market, there are significant restraints that could impede growth. One of the primary challenges is the high cost associated with neurological treatments and medications. Many advanced therapies and diagnostic tools involve substantial investments, making them less accessible to patients and healthcare systems, particularly in developing regions. This financial burden can limit patient access to essential care and may hinder overall market growth. Additionally, the complex reimbursement landscape for neurological treatments can create further obstacles, leading to delays in treatment approval and financial uncertainties for stakeholders involved. Another major restraint is the shortage of trained healthcare professionals specializing in neurology. The growing patient population and increasing complexity of neurological disorders have intensified the demand for neurologists and allied specialists. However, the existing workforce is often inadequate to meet these needs. This shortage can lead to lengthy wait times for patients seeking care, ultimately affecting diagnosis and treatment outcomes. Furthermore, the limited availability of specialized training programs in neurology poses a barrier to addressing this skill gap, thereby posing a constraint to the market’s expansion.

Explore Growth Opportunities

Request Free Sample Report
Regional Forecast

Regional Demand Dynamics

Neurology Market
Largest Region
North America
41% Market Share in 2024
North America The neurology market in North America is primarily driven by an increase in the prevalence of neurological disorders, advancements in technology, and a strong focus on research and development. The U.S. holds the largest share of the market, supported by a well-established healthcare infrastructure and high healthcare spending. Key players in the region are actively engaging in mergers and acquisitions to enhance their product offerings. Additionally, the rising awareness of mental health issues is propelling the demand for neurology services and treatments. Canada is also experiencing growth in the neurology market, influenced by government initiatives aimed at improving healthcare access and the increasing population of elderly patients susceptible to neurological conditions. Asia Pacific The Asia Pacific neurology market is witnessing substantial growth due to rising neurological disorders and increased healthcare expenditure across countries like China, Japan, and South Korea. China is rapidly advancing in the neurology sector, driven by a growing aging population and an increase in disposable income. The government is enhancing healthcare services, leading to a rise in the demand for innovative neurological therapies. Japan stands out with its advanced medical technologies and research capabilities, which are crucial in treating neurological disorders. South Korea is focusing on increasing investments in neuroscience research, leading to the development of new treatment options and enhancing patient care in the neurology market. Europe The neurology market in Europe is characterized by a strong focus on research and development, with significant investments in innovative therapeutic solutions for neurological disorders. The United Kingdom, Germany, and France are key players in this market. The UK is experiencing an increase in neurodegenerative diseases, prompting government and private sector investment in neurology research and therapies. Germany benefits from a robust healthcare infrastructure and a high number of clinical trials, leading to the introduction of advanced treatment options. France is also showing growth, attributed to increasing awareness and improving treatment facilities for neurological conditions, alongside active government policies to bolster healthcare services.
🔒 Need data on a specific country or region? Individual country/region reports are available at discounted pricing. Inquire Before Buying

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Neurology Market Segment Analysis Type The neurology market can be segmented by type into neurodegenerative diseases, neurovascular diseases, neuro-infectious diseases, and others. Neurodegenerative diseases, which include conditions such as Alzheimer's and Parkinson's, occupy a significant share of this market due to the aging population and increased prevalence of these disorders. Neurovascular diseases, including strokes and aneurysms, also represent a critical segment as they are a leading cause of morbidity and mortality globally. Neuro-infectious diseases, such as meningitis and encephalitis, while less prevalent than the neurodegenerative segment, still require substantial attention due to their acute nature and potential for severe outcomes. The 'others' category encompasses various less common neurological conditions that contribute to the overall market but tend to have limited data regarding incidence and treatment options. Procedure The procedure segment of the neurology market includes multiple sclerosis, epilepsy, Parkinson's disease, Alzheimer's disease, stroke, and others. Multiple sclerosis is increasingly recognized as a significant condition due to its chronic nature and impact on life quality, thus driving demand for advanced treatment options. Epilepsy management represents another vital procedure area, with ongoing advancements in both pharmacological and surgical interventions enhancing patient outcomes. Parkinson's and Alzheimer's diseases consistently dominate this segment owing to their high prevalence and the growing focus on developing innovative therapies. Stroke management remains a major concern given its acute nature and long-term rehabilitation needs, while 'others' include rare procedures that contribute to niche segments within the overall market. End User The end user segmentation of the neurology market is categorized into adult and pediatric populations. The adult segment commands a larger market share as neurodegenerative and neurovascular diseases predominantly affect older individuals. An aging demographic coupled with lifestyle factors continues to drive the demand for neurological interventions and care among adults. However, the pediatric segment is gaining attention due to the increasing diagnosis of neurological disorders in children, such as cerebral palsy and epilepsy, and the unique treatment requirements in this population. This focus on pediatric neurology is increasingly influencing market dynamics as healthcare providers tailor approaches specifically for younger patients. Application The neurology market is applied across various settings, including hospitals, clinics, diagnostic centers, research institutes, and others. Hospitals remain the primary application of neurology services due to their capacity for comprehensive diagnostics, acute care, and advanced treatment interventions. Clinics are crucial for ongoing management and rehabilitation of neurological disorders, contributing significantly to outpatient care. Diagnostic centers play a pivotal role in the early detection of neurological conditions, leveraging advanced imaging and laboratory capabilities. Research institutes are essential for advancing the understanding of neurological conditions and developing new therapies, while the 'others' category captures miscellaneous applications that are relevant but less defined in conventional settings.
Segment Sub-Segment Largest Segment Fastest Growing
Custom Research

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
Competitive Landscape

Competitive Landscape and Market Positioning

The competitive landscape in the Neurology Market is characterized by a diverse array of stakeholders including pharmaceutical companies, biotechnology firms, medical device manufacturers, and research organizations. Key trends include a focus on innovative therapies for neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis, which drive intense competition. Ongoing advancements in neuromodulation techniques and personalized medicine are reshaping treatment paradigms, with companies vying to differentiate their offerings through research and development. Strategic partnerships, mergers, and acquisitions are also prevalent as firms seek to expand their product portfolios and enhance their market presence, leading to a rapidly evolving competitive environment. Top Market Players 1. Pfizer Inc. 2. Novartis AG 3. Eli Lilly and Company 4. Roche Holding AG 5. Bristol-Myers Squibb Company 6. Biogen Inc. 7. Sanofi S.A. 8. Johnson & Johnson 9. AbbVie Inc. 10. Amgen Inc.
Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Report Customization

Customize Your Report

Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.

1 Custom Segments 2 Custom TOC 3 Related Reports

Neurology Market — Custom Segments

Segment Sub-Segment
No segment data available.

Neurology Market — Custom TOC

Custom Chapter Chapter Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
FAQ

Frequently Asked Questions

Testimonials

Our Clients

"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."

Project Manager
Siemens Healthcare

"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."

Research and Development (R&D) Manager
GC Biopharma

"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."

Quality Assurance Manager
Medtronic
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL
Healthcare & Medical Devices
Research Team Overview

This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team
10+Industry Verticals
100+Countries Analyzed
5-7Days Standard
Delivery
13.8K+Research Reports
Published
On-DemandCustomized Research
Available
6Months Analyst
Support
PDF + XLSReport Deliverables
Trust & Compliance
D&B D-U-N-S
GDPR & CCPA Compliant
ISO 9001 Certified (ISO 9001:2015)
SSL Encryption
Secure Payments
Confidential Handling
Research Intelligence
Primary Research Network
Secondary Sources
Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts
Research Workflow & Quality Assurance
01
Data Collection
Verified information gathered through primary and secondary research.
02
Data Triangulation
Cross-validation using multiple independent data sources.
03
Forecast Modelling
Market estimates developed using historical trends and analytical models.
04
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
05
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
06
Final Publication
Released after successful completion of the internal review process.
Report Coverage
Market Assessment
  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics
🏢 Competitive Intelligence
  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis
🚀 Future Outlook
  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →